• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Syngene

    PCI Pharma Services

    Alcami

    Reed-Lane

    Flow Sciences
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Flow Sciences

    Adare Pharma Solutions

    Cytovance Biologics

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    The “Greening” of Solid Dosage Form Manufacturing

    Going “green” can mean saving big bucks for pharma manufacturers.

    The “Greening” of Solid Dosage Form Manufacturing
    Related CONTENT
    • Mogene
    • Softweb Solutions
    • Biopharma Over 20 Years
    • German Pharma Benefiting From a Brexit Boost?
    • Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
    Emil W. Ciurczak, DoraMaxx Consulting11.20.19
    Over the past few years, I have lauded PAT (Process Analytical Technology), QbD (Quality by Design), and, of course CM (Continuous Manufacturing) as means to producing faster, less expensive, and safer drug products. What hasn’t been emphasized is the environmental effects of “better” manufacturing. Environmental matters are a large arena, so I will attempt to break down the areas where process analyses and control will help. The fact is that “going green,” in many cases, also means saving big bucks.

    Warehouse and production space
    On any given production site, the largest footprint is from the warehouses. Warehouses for raw materials, intermediate products, final products, and packaged products, ready to ship. When I worked at Merck (1991-2), West Pont, PA, I was able to walk across campus for whatever purpose. When I visited in 2005, I needed to drive to get somewhere in a reasonable time. The reason? Mainly warehouses and some labs had been constructed.

    I cannot directly address the cost per square foot of lighting and heating/air conditioning (HVAC), but assume we can cut at least 50% of our lighting and HVAC costs by not having to store intermediate (in-process) samples while waiting for either an analysis or piece of production equipment to be freed (cleaned and approved) for use in the next step of the process.

    Loss from transfer
    When the dry raw materials are transferred from storage and poured/scooped into a blender, some material is lost. When the blend is transferred to containers to another holding area to a granulator, more material is lost. During and after granulation (transfer), more is lost. In short, every time a powder blend is transferred from container to container a percentage is lost. When each process unit is washed, there is a volume of water, contaminated with detergent and API, washing down the drain.

    Cost of traditional analysis
    There are four major areas of expense: lab space, equipment, personnel, and chemicals. Let’s take a closer look at all four areas:

    1. Laboratory space. When designing and expanding the lab space, we need to include the expenses of all utilities (water, electric, gasses, and HVAC). One of the most expensive rooms to construct in a Pharma company is the lab. Many meters of gas, vacuum, and water pipes are required, plus multiple electrical outlets per section often with voltage smoothing equipment, sinks, air hoods, and so forth, are also needed.

    Also needed is the ancillary storage of solvents and chemicals in “explosion-proof” environments, which means more “brick and mortar” construction and ventilation. This means more space, electrical power, etc., all of which drive up costs.

    2. Equipment. No matter which manner of analysis a company chooses for routine analysis, capital purchases must be made. For this example, I will just compare a typical HPLC units with an NIR-based on-line (commercially available) unit.

    a. For the HPLC, a fully automated unit, capable of 30-50 samples over a 24-hour period, could cost between $35-50,000 (excluding columns, sample vials, etc.), ignoring IQ/OQ/PQ (necessary for any unit, often performed by the manufacturer). Operational costs are listed below.

    b. For an in-line NIRS unit, the cost would be around $100,000. This unit would be capable of analyzing whole capsules or tablets—for ID of API, content uniformity, and prediction of dissolution times—at a rate of 100,000 units per hour.

    c. Assuming a 3-5,000,000 tablet batch, the HPLC would be (destructively) measuring 0.007 to 0.004% of the batch for uniformity, while the NIR unit would be measuring (non-destructively) 100% of the batch using a blast of compressed air/nitrogen to eliminate any OOS sample.

    d. One of the most under-estimated time costs is the length of time needed for an HPLC assay. For illustration:
    i. Sample(s) must be gathered from production locale.
    ii. Label and transport the samples to QC.
    iii. Sign-in the samples and assign them to an analyst.
    iv. The analyst then prepares standards, performs sample preparation (grind, dissolve, filter, pipette into vials).
    v. Condition the HPLC, acquire computer files, place vials into unit and begin (15-20 min/sample).
    vi. Supervisor checks chromatograms for errors, OK’s the results, assuming a repeat is not needed, and releases or fails the batch (“failure” may just mean repeating a larger number of samples).
    vii. So, an HPLC assay without dissolution testing approaches one day in duration; the NIR time per sample is roughly 10 milliseconds, with no sample preparation.

    3. Personnel. While the actual analytical instruments may be automated, they still need personnel to do the paperwork, sample preparation, solvent/mobile phase preparation, set-up and break-down of columns, etc. Under normal conditions, one analyst is assigned or uses one HPLC. The number of lots run per day per unit will vary on the make and model as well as the difficulty of sample preparation (often, up to one hour or more), so the number of LC units needed to service a busy company will vary. In HPLC, there are both operators and maintenance personnel, while for in/at-line analysis units, the technical personnel are both operators and maintainers of the hardware.

    4. Chemicals, disposables. The cost of analysis can be estimated on an assay-by-assay basis:

    a. Assuming a single HPLC assay takes:
    i. 0.5 hour to obtain, label, and assign a sample.
    ii. 0.5 to 1.0 hour to prepare the sample for injection, taking between 250mL to 500mL of solvent per sample, normally ~50% organic solvent.
    iii. Between 10 to 30 minutes elution time per sample.
    iv. At 1.0 to 1.5 mL/min of mobile phase, each sample could use 10 to 45mL of solvent, per sample.

    b. The cost of one sample can then be estimated, if only for the expendables, ignoring HVAC and salaries of the people doing the work.
    i. Assume that HPLC grade solvents may cost $25-$50 per liter.
    ii. For a single sample, the cost could be (low vs. high)

    1. 1.0mL/min x 10 min x $25/L x 1.0L/1000mL x 50% = $0.13 (low)

    2. 1.5mL/min x 15 min x $50/L x 1.0L/1000mL x 50% = $1.13 (hi)
    iii. If a content uniformity were performed (10 samples, pre- and post-standards), we can “spend” $1.13/sample x 22 samples (and standards) = $24.75 in solvent used.
    iv. Add to that the cost and time of sample prep and the cost per sample increases even more.
    v. And, unless times have changed, it costs more to (legally) dispose of the solvents than to purchase them.

    c. Assume 50-60 lots of drug per week (with no re-runs or errors):
    i. For the short/fast runs; $0.13 x 22 samples x 50 lots = $143 in solvents.
    ii. For long/slower runs; $1.13 x 22 samples x 60 lots = $191.60 in solvents, alone.
    iii. The cost of disposal must include storage, transport, paperwork, fees for storage at final site, etc. Aside from all steps having toxic chemicals and chance of spillage or human exposure, double the cost per assay.

    d. The exact cost of filters, injection vials, and columns will vary, but could well equal the cost of solvents and may be more stressful on disposal sites than the actual solvents (which, in some cases may be recycled or burned).

    e. While the exact number of calibrated glassware needed varies, the need for washing and storing them must be considered: washing requires water (cost plus usage), detergents, and drying (often heated). All use electricity, which is often generated from fossil fuel… not to mention burden on the sewage system.

    Cost of quality
    Clearly, something as drastic as a product recall would be financially disastrous—cost of product, transportation costs, off-the-shelf-time, reputation diminishing, fines from FDA—but would also exacerbate the environmental problems. If nothing else, the replacement batch would have the same losses as the recalled batch (process losses, transportation emissions, etc.) and the recalled batch would need to be safely destroyed and disposed. The disposed/destroyed lot also poses the same environmental problems as the rinse-water from equipment cleaning (or spillage of and/or improper handling of solvents), but on a much larger scale.

    The API might be recovered prior to disposal, but that involves more solvents, which will eventually need to be disposed of or allowed to evaporate. The former has the potential to contaminate groundwater while the latter is a clean air hazard.

    Observation and suggestion
    Moving from “traditional” batch-style production to a simple PAT-mode will alone speed up production and minimize losses both financially and environmentally. Adding QbD will make for fewer OOS batches, avoiding batch destruction or recall. When, and if, real-time release (in-line measurements of final product) is added, the cost saving goes up by far more—zero recalled batches and a massive avoidance of lab-based assays.

    More than a decade of accepted and successful submissions to the FDA and EMA have shown that end-of-process NIR (or Raman) monitoring can provide identification (verification of ID and level) of the API, API assay, content uniformity, and, for a bonus, dissolution predictions may be generated. All these save transportation (to the lab) time, solvents, columns, labor, etc.

    When you are ready for the “big time,” continuous manufacturing is the “trifecta” of all these savings. There would be no transfer losses (with cleaning pollution), no lab solvent usage (destructive assays and labor costs), and real-time release. As an added attraction, the “footprint” of the process will be a mere fraction of batch processing and the warehouses need not be built. A win-win-win for the company, patient, and environment. 


    Emil W. Ciurczak
    DoraMaxx Consulting

    Emil W. Ciurczak has worked in the pharmaceutical industry since 1970 for companies that include Ciba-Geigy, Sandoz, Berlex, Merck, and Purdue Pharma, where he specialized in performing method development on most types of analytical equipment. In 1983, he introduced NIR spectroscopy to pharmaceutical applications, and is generally credited as one of the first to use process analytical technologies (PAT) in drug manufacturing and development.
    Related Searches
    • Dosage
    • Pharma
    • Manufacturing
    • drying
    Suggested For You
    Mogene Mogene
    Softweb Solutions Softweb Solutions
    Biopharma Over 20 Years Biopharma Over 20 Years
    German Pharma Benefiting From a Brexit Boost? German Pharma Benefiting From a Brexit Boost?
    Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
    Vetio Animal Health Vetio Animal Health
    A Witness to the Growth of Outsourcing A Witness to the Growth of Outsourcing
    Highly Potent Expansions Highly Potent Expansions
    The Bioprocessing Trek The Bioprocessing Trek
    Quality Metrics Feedback Quality Metrics Feedback
    Changing the Face of CDMOs Changing the Face of CDMOs
    FDA Extends CRADA with CluePoints FDA Extends CRADA with CluePoints
    Northwest Biotherapeutics Expands Senior Management Team Northwest Biotherapeutics Expands Senior Management Team
    NIIMBL, FDA to Advance Innovation in Bio Manufacturing NIIMBL, FDA to Advance Innovation in Bio Manufacturing
    Merck to Build $650M Biomanufacturing Plant in NC Merck to Build $650M Biomanufacturing Plant in NC

    Related Columns

    • A Potential “Marriage”

      A Potential “Marriage”

      Initiator companies and generics/CMOs working together.
      Emil W. Ciurczak, DoraMaxx Consulting 11.17.20

    • When Politics and Science Collide

      When Politics and Science Collide

      COVID-19 illustrates why science should always be a principal informer of politics to make better and smarter decisions.
      Ben Locwin, Contributing Editor 11.17.20

    • The Pandemic’s Become an Insurmountable Opportunity

      The Pandemic’s Become an Insurmountable Opportunity

      Every Cloud has a Silver Lining(?)
      Emil W. Ciurczak, Contributing Editor 10.14.20


    • Biologics, Proteins, Vaccines
      It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]

      It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]

      Race for the vaccines is heating up.
      Ben Locwin, Contributing Editor 09.09.20

    • cGMP Manufacture
      Keys to Biotech Success

      Keys to Biotech Success

      Four steps emerging biotech companies can take to achieve success
      Thierry Cournez, Head of End-to-End Solutions, MilliporeSigma 06.04.20

    • Analytical Services
      What Happens When the All-Clear Signal is Given?

      What Happens When the All-Clear Signal is Given?

      Maybe 3M had some good ideas?
      Emil W. Ciurczak, DoraMaxx Consulting 06.04.20


    • Almost Like the Olympics:

      Almost Like the Olympics:

      “Smaller, Faster, Smarter”
      Emil W. Ciurczak, DoraMaxx Consulting 05.05.20

    • Rapid Delivery of Medical Countermeasures Amid Pandemic

      Rapid Delivery of Medical Countermeasures Amid Pandemic

      Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccines
      Kristin Brooks, Managing Editor, Contract Pharma 05.05.20

    • The Supply Chain House of Cards

      The Supply Chain House of Cards

      The COVID-19 pandemic exposes pressures on extended global supply chains
      Emil W. Ciurczak, DoraMaxx Consulting 04.01.20


    • Analytical Services | Laboratory Testing
      The Supply Chain, as Developed by IKEA (some assembly required)

      The Supply Chain, as Developed by IKEA (some assembly required)

      Pick One from Column A, Two from Column B, etc.
      Emil W. Ciurczak, DoraMaxx Consulting 03.04.20

    • Coronavirus 2020

      Coronavirus 2020

      What’s The Impact To The World and Industry?
      Ben Locwin, Contributing Editor 03.04.20

    • Supply Chain
      What We Have is Failure to Communicate

      What We Have is Failure to Communicate

      When it comes to implementing track and trace technology, why is Pharma dragging its feet?
      Emil W. Ciurczak, DoraMaxx Consulting 01.28.20


    • Vision: 2020

      Vision: 2020

      You have exactly 366 days in 2020 to bring your clarity of vision to reality.
      Ben Locwin 01.28.20

    • When Life Gives You Lemons…Raise Your Drug Prices

      When Life Gives You Lemons…Raise Your Drug Prices

      The hidden effect of economic models on global drug supply and shortages.
      Ben Locwin 11.20.19

    • Like It’s 1999

      Like It’s 1999

      Reflecting on 20 years of Contract Pharma.
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 10.15.19

    Trending
    • Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • Precision Medicine Group Acquires Project Farma
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Eriocitrin Shown to Have Metabolic Benefits in Recent Study
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    Amyris Named a Top Social & Environmental Impact Company
    L'Oréal Bans Animal Hair in Brushes
    Ashland Launches Antaron ECo Gel
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login